1.Make efforts to improve overall levels of clinical nutriology in China.
Chinese Journal of Gastrointestinal Surgery 2012;15(5):426-428
Clinicians should assume the responsibility of nutritional therapy for satisfactory outcomes. They should master knowledge on nutritional metabolism, and participate in the administration of nutritional support. Clinicians should be acquainted with new concepts and standardized techniques in this field, such as different requirement of energy, understanding of early nutritional support, and optimal regimens of enteral or parenteral nutrition.
China
;
Enteral Nutrition
;
Humans
;
Nutritional Support
;
Parenteral Nutrition
2.TOAST subtypes, risk factors and recurrence of ischemic stroke
Chinese Journal of General Practitioners 2009;8(4):230-233
Objective To analyse subtyping of iscbemic stroke by the criteria of Trial of Org 10 172 in Acute Stroke Treatment (TOAST), its distribution, and relationship between TOAST subtypes, its risk factors and recurrence. Methods Clinical data of 441 patients of ischemic stroke were collected prospectively during October 1, 2006 to September 30, 2007. All the patients were classified by TOAST criteria into five major subtypes and followed-up for one year since its first episode. Dates of its recurrence and death due to recurrence were recorded. Results All the 441 patients with ischemic stroke could be subtyped etiologically according to TOAST criteria as follows: etiology undetermined in 42.3 percent, small-vessel occlusion in 30.9 percent, large-artery atherosclerosis in 17.3 percent, cardioembolism in 9.3 percent, and others in 0.2 percent, without statistically significant difference in its gender and age distributions. Recurrence rate of iscbemic stroke in one year since its first episode for varied subtypes was 33.3 percent for cardioembolism, 14. 6 percent for etiology undetermined, 13.7 percent for large-artery atherosclerosis and 6.9 percent for small-vessel occlusion, respectively. There was no significant difference in risk factors for varied subtypes of iscbemic stroke, including history of smoking, hypertension, diabetes, cardiac disease, and serum levels of total cholesterol, low-density lipoprotein cholesterol, fihrinogen and glucose. Conclusions Varied subtypes of iscbemic stroke had different risk factors and recurrence rate by TOAST criteria, which can be used as an etiologic classification for its secondary prevention.
3.Correlation between human leukocyte antigen G and gynecological neoplasms
Journal of International Oncology 2009;36(2):144-146
The immune tolerance or immune escape plays important roles in the genesis and progression of malignant gynecological neoplasms.Human leukocyte antigen G(HLA-G)is an important member of major histocompatiblity complex class Ⅰ.HLA-G seems to affect almost every aspect of human immunity.It can inhibit immunological function,and play an important role in immune escape of malignant gynecological neoplasms.
4.Relationship between COX-2 and breast cancer
International Journal of Surgery 2008;35(8):561-564
Cycloxygenase-2 plays an important role in many human tumorigenesis, and is overexpressod in breast cancer. Therefore, it is necessary to investigate the relationship between COX-2 and breast cancer, and to develop the desirable COX-2 inhibitor. These can privide a new antitumor method.
5.Common fabrication technology of the scaffolds for cartilage tissue engineering
Chinese Journal of Tissue Engineering Research 2007;0(19):-
With the development of cartilage tissue engineering, how to achieve an ideal scaffold has become the difficult and hot spot in this study field. The scaffold for cartilage tissue engineering should provide with some special physical and biochemical properties, such as excellent biocompatibility, proper biodegradability, controlled porosity, adequate pore size and so on. Such properties are closely related to two factors, one is the materials used for scaffolds, the other is the fabrication technology. This review is concentrated on the present common fabrication technologies of three-dimensional porous scaffolds, and mainly introduces the following technologies: solvent casting/particulate leaching, phase separation/freeze-drying, hydrogels, gas foaming, electrospinning and rapid prototyping manufacturing. Those fabrication technologies' effects on structure and properties of scaffolds have been compared to summarize and analyze the advantages and disadvantages of every fabrication technology, and simultaneously prospect the developing tendency of fabrication technology in cartilage tissue engineering.
6.The new management strategy of the hypertension in the very elderly
Chinese Journal of Practical Internal Medicine 2001;0(09):-
80 years)in China is increasing.As a special type of hypertension,the hypertension in the very elderly has some specificities in pathogenesis,clinical manifestation,treatment and prognosis.The topic to effectively cure and prevent hypertension in the very elderly is increasingly emphasiced.This article presents an overview of recent progress in clinical characteristics,and treatment strategy related to hypertension in the very elderly.
7.Application of enzyme catalytic reaction with ultrasonic wave to Chinese materia medica and natural products
Chinese Traditional and Herbal Drugs 1994;0(08):-
The enzyme,as a biocatalyst,can not be surpassed in speeding up the reactions by other common chemical catalysts under the suitable conditions and can catalyze the reaction mildly,simplify the facilities needed,improve the work conditions,and reduce the production costs,etc.Those are its advantages mentioned above.But while the enzyme is extracted outside the cells,the molecular conformation may be changed with decreasing its bioactivity and stability seriously.As one type of physical energy,(ultrasonic) wave with lower intensity and suitable frequency can make the conformation of enzymatic molecular comformation transform positively and the transforming reactions accelerate so as to facilitate the effective constituents of Chinese materia medica and natural products transforming.
8.Advances in The Research of Diseases Related to Notch Signaling Pathway
Progress in Biochemistry and Biophysics 2006;0(12):-
Notch signaling pathway plays a vital role in cell fate decisions. Notch signals are transferred among adjacent cells through Notch receptors and their ligands, which can regulate differentiation, proliferation and apoptosis of many cell types including stem cells. They can also influence organ formation and morphopoiesis. Genetic mutations in the Notch signaling pathway are related to the emergence and development of many diseases. Notch signaling pathway is increasingly becoming important drug targets for cancer, hereditary disease such as CADASIL and other related diseases. It is also used to develop stem cell therapeutics to treat age or trauma related degenerative diseases such as Alzheimer's disease, Parkinson disease and diabetes.
9.The development of scaffolds in cartilage tissue engineering
Journal of Medical Postgraduates 2004;0(01):-
The scaffold for cartilage tissue engineering should have special physical and biochemical properties,such as excellent biocompatibility,proper biodegradability,controlled porosity,adequate pore size,etc.With the development of cartilage tissue engineering,how to achieve ideal scaffolds is becoming a hot spot in this field.This review outlines the advances in the studies of scaffolds in cartilage tissue engineering.
10.Progress in dendritic cell and immunotherapy of childhood acute lymphoblastic leukemia
International Journal of Pediatrics 2010;37(1):75-77,81
Because of the exists of minimal residual disease(MRD), children with acute lymphoblastic leukemia (ALL) often suffer from recurrence. Dendritic cells (DC) play a pivotal role in the body's anti-tumor immune response through taking up tumor antigens to stimulate the body's immune system.Therefore it has become a hotspot due to DC's immunotherapy of clearing MRD in the body of children with ALL. This review discusses the DC characteristics, the immune escape mechanism associated with DC and the use of DC's immunotherapy in children with ALL.